← Back to Search

Group 1 (MRI) for Prostate Cancer

N/A
Recruiting
Led By Stephen J. Riederer, Ph.D.
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adults
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (at enrollment); possible second scan at a later date
Awards & highlights

Study Summary

This study evaluates contrast-enhanced MR angiography and contrast-enhanced MR perfusion imaging for the visualization of blood vessels and enhancing tissues with better spatial detail and improved temporal fidelity compared to current methods.

Eligible Conditions
  • Prostate Cancer

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (at enrollment); possible second scan at a later date
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (at enrollment); possible second scan at a later date for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Improved performance in contrast-enhanced magnetic resonance imaging (MRI) as used for angiography and perfusion

Trial Design

3Treatment groups
Experimental Treatment
Group I: Group 3 (MRIs with contrast)Experimental Treatment1 Intervention
Participants receive gadolinium based MR contrast agent IV and undergo up to two MRIs on study. Participants may also undergo blood sample collection on study.
Group II: Group 2 (MRI with contrast)Experimental Treatment1 Intervention
Participants receive gadolinium based MR contrast agent IV and undergo a MRI on study. Participants may also undergo blood sample collection on study.
Group III: Group 1 (MRI)Experimental Treatment1 Intervention
Participants undergo MRI on study. Participants may also undergo blood sample collection on study.

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,207 Previous Clinical Trials
3,766,840 Total Patients Enrolled
34 Trials studying Prostate Cancer
8,388 Patients Enrolled for Prostate Cancer
National Cancer Institute (NCI)NIH
13,659 Previous Clinical Trials
40,924,389 Total Patients Enrolled
561 Trials studying Prostate Cancer
507,113 Patients Enrolled for Prostate Cancer
National Institute for Biomedical Imaging and Bioengineering (NIBIB)NIH
89 Previous Clinical Trials
19,484 Total Patients Enrolled
5 Trials studying Prostate Cancer
175 Patients Enrolled for Prostate Cancer

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Improvements in Dynamic Contrast-Enhanced MR Angiography and Perfusion
2015. "Improvements in Dynamic Contrast-Enhanced MR Angiography and Perfusion". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06315595.
All > Phoenix > Paid Studies Minneapolis
~128 spots leftby Sep 2030
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top